UiPath (PATH) Stock Declines While Market Improves: Some Information for Investors

Zacks
Open on Zacks
UiPath (PATH) Stock Declines While Market Improves: Some Information for Investors

UiPath (PATH) closed the most recent trading day at $11.68, moving -1.02% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.42%. Meanwhile, the Dow experienced a rise of 0.29%, and the technology-dominated Nasdaq saw an increase of 0.29%.

Prior to today's trading, shares of the enterprise automation software developer had gained 10.8% outpaced the Computer and Technology sector's gain of 0.85% and the S&P 500's gain of 2.2%.

Investors will be eagerly watching for the performance of UiPath in its upcoming earnings disclosure. In that report, analysts expect UiPath to post earnings of $0.15 per share. This would mark no growth from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $397.59 million, showing a 9.91% escalation compared to the year-ago quarter.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.8 per share and a revenue of $1.78 billion, indicating changes of +11.11% and +10.4%, respectively, from the former year.

Investors should also take note of any recent adjustments to analyst estimates for UiPath. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 6.13% rise in the Zacks Consensus EPS estimate. UiPath is holding a Zacks Rank of #2 (Buy) right now.

Investors should also note UiPath's current valuation metrics, including its Forward P/E ratio of 14.75. This indicates a discount in contrast to its industry's Forward P/E of 19.73.

Investors should also note that PATH has a PEG ratio of 0.7 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Internet - Software industry had an average PEG ratio of 1.06 as trading concluded yesterday.

The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 92, putting it in the top 38% of all 250+ industries.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
UiPath, Inc. (PATH): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research